Who is the CEO of ALMS? | Glauxie AI

Q: Who is the CEO of ALMS?

Alumis Inc. Common Stock (ALMS) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Martin Babler. Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2... Employees: 221.

Q: What does ALMS company do?

Learn what ALMS does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling ALMS?

Track recent insider buys and sells for ALMS with transaction details, amounts, and trends.

Q: What sector is ALMS in?

Find ALMS sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of ALMS?

🦉

Alumis Inc. Common Stock (ALMS)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMartin Babler

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis, systemic lupus erythematosus, and...

Key Executives

Name	Title
Claire Langrish	Senior Vice President & Head of Immunology and Translational Science
David Goldstein	Chief Scientific Officer
Grace Halteh	Senior Vice President & Head of Quality and Regulatory
Jack Danilkowicz	Chief Commercial Officer
John R. Schroer	Chief Financial Officer
Jorn Drappa	Chief Medical Officer & Head of Research and Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ALMS Profile Financials

What does ALMS company do? Are insiders buying or selling ALMS? What sector is ALMS in?